BLOOD, LYMPH AND RELATED CONDITIONS:@0.084848:0.038601:0.564720:0.038601:0.564720:0.019343:0.084848:0.019343:0.013500:0.010866:0.020438:0.020438:0.017498:0.006515:0.006515:0.008735:0.013923:0.021613:0.013923:0.016063:0.006515:0.017404:0.017404:0.017498:0.006515:0.014276:0.012606:0.010866:0.015466:0.010019:0.012606:0.017498:0.006515:0.019121:0.020438:0.017404:0.017498:0.005315:0.010019:0.005315:0.020438:0.017404:0.011712
104:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
Table 3. The three clinical lymphoma groups and the approach to treatment:@0.084848:0.096166:0.777575:0.096166:0.777575:0.080132:0.084848:0.080132:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.007889:0.011353:0.012123:0.005195:0.005580:0.011353:0.005965:0.012123:0.012123:0.005195:0.012123:0.004426:0.004426:0.011353:0.004426:0.012123:0.012508:0.004426:0.005195:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012508:0.005195:0.012508:0.005965:0.012123:0.011353:0.012508:0.008274:0.005195:0.012508:0.011353:0.012508:0.005195:0.005580:0.011353:0.012123:0.005195:0.012508:0.012508:0.012508:0.005965:0.012123:0.012508:0.012123:0.011353:0.005195:0.005580:0.012123:0.005195:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005773
Clinical :@0.094474:0.126918:0.168551:0.126918:0.168551:0.110884:0.094474:0.110884:0.014817:0.004426:0.004426:0.011353:0.004426:0.012123:0.012508:0.004612:0.005388
lymphoma :@0.094474:0.143084:0.199732:0.143084:0.199732:0.127050:0.094474:0.127050:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012702:0.005388
disease :@0.094474:0.159250:0.170291:0.159250:0.170291:0.143216:0.094474:0.143216:0.012508:0.004426:0.008274:0.012123:0.012508:0.008274:0.012317:0.005388
expression:@0.094474:0.175416:0.192418:0.175416:0.192418:0.159382:0.094474:0.159382:0.012123:0.010583:0.012508:0.005965:0.012123:0.008274:0.008274:0.004426:0.012123:0.011545
Initial :@0.221204:0.126905:0.274692:0.126905:0.274692:0.110871:0.221204:0.110871:0.005195:0.011353:0.004426:0.005580:0.004426:0.012508:0.004612:0.005388
treatment :@0.221204:0.143071:0.315486:0.143071:0.315486:0.127037:0.221204:0.127037:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005767:0.005388
approach :@0.221204:0.159237:0.318380:0.159237:0.318380:0.143203:0.221204:0.143203:0.012508:0.012508:0.012508:0.005965:0.012123:0.012508:0.012123:0.011547:0.005388
and timing  regimens:@0.221204:0.175403:0.423981:0.175390:0.423981:0.159356:0.221204:0.159369:0.012508:0.011353:0.012508:0.005195:0.005580:0.004426:0.017895:0.004426:0.011353:0.012702:0.005388:0.014584:0.005965:0.012123:0.012508:0.004426:0.017895:0.012123:0.011353:0.807240
of therapy:@0.221204:0.191569:0.314915:0.191569:0.314915:0.175535:0.221204:0.175535:0.012123:0.005195:0.005195:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161
Common :@0.339122:0.126892:0.430910:0.126892:0.430910:0.110858:0.339122:0.110858:0.014817:0.012123:0.017895:0.017895:0.012123:0.011547:0.005388
chemotherapy :@0.339122:0.143058:0.481323:0.143058:0.481323:0.127024:0.339122:0.127024:0.012123:0.011353:0.012123:0.017895:0.012123:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161:0.005388
treatment :@0.339122:0.159224:0.433406:0.159224:0.433406:0.143190:0.339122:0.143190:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005769:0.005388
- Note that :@0.339122:0.199890:0.441872:0.199890:0.441872:0.183856:0.339122:0.183856:0.007889:0.005195:0.014047:0.012123:0.005580:0.012123:0.005195:0.005580:0.011353:0.012508:0.005769:0.005388
rituximab forms :@0.339122:0.216056:0.484594:0.216056:0.484594:0.200022:0.339122:0.200022:0.005965:0.004426:0.005580:0.011353:0.010583:0.004426:0.017895:0.012508:0.012508:0.005195:0.005195:0.012123:0.005965:0.017895:0.008467:0.005388
an integral part :@0.339122:0.232222:0.484398:0.232222:0.484398:0.216188:0.339122:0.216188:0.012508:0.011353:0.005195:0.004426:0.011353:0.005580:0.012123:0.012508:0.005965:0.012508:0.004426:0.005195:0.012508:0.012508:0.005965:0.005769:0.005388
of most B-cell :@0.339122:0.248388:0.468232:0.248388:0.468232:0.232354:0.339122:0.232354:0.012123:0.005195:0.005195:0.017895:0.012123:0.008274:0.005580:0.005195:0.010968:0.007889:0.012123:0.012123:0.004426:0.004612:0.005388
lymphoma :@0.339122:0.264554:0.444380:0.264554:0.444380:0.248520:0.339122:0.248520:0.004426:0.010968:0.017895:0.012508:0.011353:0.012123:0.017895:0.012702:0.005388
chemotherapy :@0.339122:0.280720:0.481323:0.280720:0.481323:0.264687:0.339122:0.264687:0.012123:0.011353:0.012123:0.017895:0.012123:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161:0.005388
regimens:@0.339122:0.296886:0.423981:0.296886:0.423981:0.280853:0.339122:0.280853:0.005965:0.012123:0.012508:0.004426:0.017895:0.012123:0.011353:0.008467
Stem-cell and :@0.518980:0.126865:0.652525:0.126865:0.652525:0.110831:0.518980:0.110831:0.009814:0.005580:0.012123:0.017895:0.007889:0.012123:0.012123:0.004426:0.004426:0.005195:0.012508:0.011353:0.012702:0.005388
biological* treatment  treatment :@0.518980:0.143031:0.826834:0.143031:0.826834:0.126997:0.518980:0.126997:0.012508:0.004426:0.012123:0.004426:0.012123:0.012508:0.004426:0.012123:0.012508:0.004426:0.008274:0.005195:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005769:0.005388:0.014224:0.005580:0.005965:0.012123:0.012508:0.005580:0.017895:0.012123:0.011353:0.005767:0.448375
possibilities:@0.518980:0.159197:0.620965:0.159197:0.620965:0.143163:0.518980:0.143163:0.012508:0.012123:0.008274:0.008274:0.004426:0.012508:0.004426:0.004426:0.004426:0.005580:0.004426:0.012123:0.008467
Expected :@0.732552:0.126865:0.825497:0.126865:0.825497:0.110831:0.732552:0.110831:0.009814:0.010583:0.012508:0.012123:0.012123:0.005580:0.012123:0.012704:0.005388
outcome:@0.732552:0.159197:0.816064:0.159197:0.816064:0.143163:0.732552:0.143163:0.012123:0.011353:0.005580:0.012123:0.012123:0.017895:0.012315
Low-grade :@0.094455:0.319310:0.200673:0.319310:0.200673:0.303091:0.094455:0.303091:0.008467:0.012315:0.015394:0.008082:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388
or indolent :@0.094455:0.335476:0.199133:0.335476:0.199133:0.319257:0.094455:0.319257:0.012315:0.006158:0.005388:0.004618:0.011545:0.012700:0.012315:0.004618:0.012315:0.011545:0.005773:0.005388
lymphoma:@0.094455:0.351642:0.195670:0.351642:0.195670:0.335423:0.094455:0.335423:0.004618:0.011161:0.018088:0.012700:0.011545:0.012315:0.018088:0.012700
Treat lym-:@0.221185:0.319310:0.310622:0.319310:0.310622:0.303554:0.221185:0.303554:0.007620:0.005713:0.012508:0.013143:0.006523:0.005330:0.003848:0.010314:0.018049:0.006388
phoma :@0.221185:0.335476:0.295172:0.335476:0.295172:0.319720:0.221185:0.319720:0.013123:0.011738:0.012604:0.018049:0.013143:0.005330
sympto-:@0.221185:0.351642:0.295653:0.351642:0.295653:0.335886:0.221185:0.335886:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.006388
matically, :@0.221185:0.367808:0.317012:0.367808:0.317012:0.352052:0.221185:0.352052:0.018049:0.013143:0.006523:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.005330
i.e., based  CVP:@0.221185:0.383974:0.379646:0.381619:0.379646:0.365863:0.221185:0.368218:0.003848:0.005330:0.012508:0.005330:0.005330:0.005330:0.013123:0.013143:0.007466:0.012508:0.013181:0.005330:0.015490:0.015644:0.013508:0.554125
on effects :@0.221185:0.400140:0.319770:0.400140:0.319770:0.384384:0.221185:0.384384:0.012604:0.011738:0.005330:0.012508:0.006086:0.006042:0.012508:0.012450:0.006523:0.007466:0.005330
of disease :@0.221185:0.416306:0.320611:0.416306:0.320611:0.400550:0.221185:0.400550:0.012604:0.006042:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
burden.:@0.221185:0.432472:0.294441:0.432472:0.294441:0.416716:0.221185:0.416716:0.013123:0.011699:0.005677:0.013181:0.012508:0.011738:0.005330
If asymp-:@0.221185:0.448638:0.305390:0.448638:0.305390:0.432882:0.221185:0.432882:0.004349:0.006042:0.005330:0.013143:0.007466:0.010314:0.018049:0.013123:0.006388
tomatic, :@0.221185:0.464804:0.304986:0.464804:0.304986:0.449048:0.221185:0.449048:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330:0.005330
watch :@0.221185:0.480970:0.286359:0.480970:0.286359:0.465214:0.221185:0.465214:0.015990:0.013143:0.006523:0.012450:0.011738:0.005330
and wait:@0.221185:0.497136:0.304081:0.497136:0.304081:0.481380:0.221185:0.481380:0.013143:0.011738:0.013181:0.005330:0.015990:0.013143:0.003848:0.006523
Bendamustine:@0.339102:0.319283:0.472549:0.319283:0.472549:0.303527:0.339102:0.303527:0.011045:0.012508:0.011738:0.013181:0.013143:0.018049:0.011699:0.007466:0.006523:0.003848:0.011738:0.012508
CHOP/CHOEP:@0.339102:0.350451:0.471625:0.350451:0.471625:0.334695:0.339102:0.334695:0.015644:0.013143:0.016722:0.011392:0.008409:0.015644:0.013143:0.016722:0.010314:0.011392
FC:@0.339102:0.412787:0.364079:0.412787:0.364079:0.397031:0.339102:0.397031:0.009333:0.015644
Ibrutinib* – a bruton :@0.518961:0.319297:0.706748:0.319297:0.706748:0.303541:0.518961:0.303541:0.004349:0.013123:0.005792:0.011699:0.006523:0.003848:0.011738:0.003848:0.013123:0.008178:0.005330:0.009621:0.005330:0.013143:0.005330:0.013123:0.005792:0.011699:0.006523:0.012604:0.011738:0.005330
kinase inhibitor:@0.518961:0.334880:0.655717:0.334880:0.655717:0.319125:0.518961:0.319125:0.009660:0.003848:0.011738:0.013143:0.007466:0.012508:0.005330:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792
Curative treatment :@0.518961:0.366048:0.702659:0.366048:0.702659:0.350292:0.518961:0.350292:0.015644:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.006523:0.005705:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
with allogeneic :@0.518961:0.381632:0.667166:0.381632:0.667166:0.365876:0.518961:0.365876:0.015990:0.003848:0.006523:0.011738:0.005330:0.013143:0.003848:0.003848:0.012604:0.012950:0.012508:0.011738:0.012508:0.003848:0.012450:0.005330
stem-cell transplant :@0.518961:0.397216:0.706248:0.397216:0.706248:0.381460:0.518961:0.381460:0.007466:0.006523:0.012508:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.005330
is reserved for young  Intent is to reduce :@0.518961:0.412800:0.905712:0.412827:0.905712:0.397071:0.518961:0.397044:0.003848:0.007466:0.005330:0.005717:0.012508:0.007466:0.012508:0.005792:0.010660:0.012508:0.013181:0.005330:0.006042:0.012604:0.005792:0.005330:0.010314:0.012604:0.011699:0.011738:0.012950:0.005330:0.016854:0.004349:0.011738:0.006523:0.012508:0.011738:0.006523:0.005330:0.003848:0.007466:0.005330:0.006523:0.012604:0.005330:0.005694:0.012508:0.013181:0.011699:0.012450:0.012508:-0.023395
patients with a high :@0.518961:0.428384:0.706671:0.428384:0.706671:0.412628:0.518961:0.412628:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330:0.013143:0.005330:0.011738:0.003848:0.012950:0.011738:0.005330
burden of disease:@0.518961:0.443968:0.686312:0.443968:0.686312:0.428212:0.518961:0.428212:0.013123:0.011699:0.005677:0.013181:0.012508:0.011738:0.005330:0.012604:0.006042:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
Largely non- :@0.732533:0.319323:0.853106:0.319323:0.853106:0.303567:0.732533:0.303567:0.008890:0.013143:0.005807:0.012950:0.012508:0.003848:0.010314:0.005330:0.011738:0.012604:0.011738:0.006373:0.005330
curative  :@0.732533:0.334907:0.819816:0.334907:0.819816:0.319151:0.732533:0.319151:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.005330
treatment –  :@0.732533:0.350491:0.851355:0.350491:0.851355:0.334735:0.732533:0.334735:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.009621:0.005317:0.005330
unless allogeneic :@0.732533:0.366075:0.897363:0.366075:0.897363:0.350319:0.732533:0.350319:0.011699:0.011738:0.003848:0.012508:0.007466:0.007466:0.005330:0.013143:0.003848:0.003848:0.012604:0.012950:0.012508:0.011738:0.012508:0.003848:0.012450:0.005330
stem-cell :@0.732533:0.381659:0.821452:0.381659:0.821452:0.365903:0.732533:0.365903:0.007466:0.006523:0.012508:0.018049:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330
transplant.  :@0.732533:0.397243:0.841560:0.397243:0.841560:0.381487:0.732533:0.381487:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.005330:0.005330:0.005330
disease burden :@0.732533:0.428411:0.881246:0.428411:0.881246:0.412655:0.732533:0.412655:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.013123:0.011699:0.005684:0.013181:0.012508:0.011738:0.005330
and  :@0.732533:0.443995:0.781254:0.443995:0.781254:0.428239:0.732533:0.428239:0.013143:0.011738:0.013181:0.005330:0.005330
restore to :@0.732533:0.459579:0.825348:0.459579:0.825348:0.443823:0.732533:0.443823:0.005713:0.012508:0.007466:0.006523:0.012604:0.005707:0.012508:0.005330:0.006523:0.012604:0.005330
asymptomatic :@0.732533:0.475163:0.873098:0.475163:0.873098:0.459407:0.732533:0.459407:0.013143:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330
state:@0.732533:0.490746:0.778695:0.490746:0.778695:0.474991:0.732533:0.474991:0.007466:0.006523:0.013143:0.006523:0.012508
High-grade :@0.094435:0.519639:0.206426:0.519639:0.206426:0.503420:0.094435:0.503420:0.013085:0.004618:0.012700:0.011545:0.008082:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388
or aggres-:@0.094435:0.535805:0.191417:0.535805:0.191417:0.519586:0.094435:0.519586:0.012315:0.006158:0.005388:0.012700:0.012700:0.012700:0.006158:0.012315:0.008467:0.008082
sive lym-:@0.094435:0.551971:0.177928:0.551971:0.177928:0.535752:0.094435:0.535752:0.008467:0.004618:0.010776:0.012315:0.005388:0.004618:0.011161:0.018069:0.008082
phoma:@0.094435:0.568137:0.161784:0.568137:0.161784:0.551918:0.094435:0.551918:0.012700:0.011545:0.012315:0.018088:0.012700
Treat ag-:@0.221166:0.519626:0.304483:0.519626:0.304483:0.503870:0.221166:0.503870:0.007620:0.005713:0.012508:0.013143:0.006523:0.005330:0.013143:0.012950:0.006388
gressively :@0.221166:0.535792:0.313774:0.535792:0.313774:0.520036:0.221166:0.520036:0.012950:0.005709:0.012508:0.007466:0.007466:0.003848:0.010660:0.012508:0.003848:0.010314:0.005330
and with-:@0.221166:0.551958:0.309046:0.551958:0.309046:0.536202:0.221166:0.536202:0.013143:0.011738:0.013181:0.005330:0.015990:0.003848:0.006523:0.011738:0.006388
out delay,  ABVD +/- :@0.221166:0.568124:0.429311:0.566351:0.429311:0.550595:0.221166:0.552368:0.012604:0.011699:0.006523:0.005330:0.013181:0.012508:0.003848:0.013143:0.010314:0.005330:0.005330:0.018107:0.014239:0.011045:0.013508:0.014316:0.005330:0.011661:0.008409:0.006388:0.229698
even if :@0.221166:0.584290:0.289130:0.584290:0.289130:0.568534:0.221166:0.568534:0.012508:0.010660:0.012508:0.011738:0.005330:0.003848:0.006042:0.005330
only a :@0.221166:0.600456:0.283473:0.600456:0.283473:0.584700:0.221166:0.584700:0.012604:0.011738:0.003848:0.010314:0.005330:0.013143:0.005330
small :@0.221166:0.616622:0.272851:0.616622:0.272851:0.600866:0.221166:0.600866:0.007466:0.018049:0.013143:0.003848:0.003848:0.005330
disease :@0.221166:0.632788:0.296615:0.632788:0.296615:0.617032:0.221166:0.617032:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
burden:@0.221166:0.648954:0.289091:0.648954:0.289091:0.633198:0.221166:0.633198:0.013123:0.011699:0.005677:0.013181:0.012508:0.011738
Ist line::@0.339083:0.519599:0.400024:0.519599:0.400024:0.503843:0.339083:0.503843:0.004349:0.007466:0.006523:0.005330:0.003848:0.003848:0.011738:0.012508:0.005330
CHOP:@0.339083:0.535183:0.395983:0.535183:0.395983:0.519427:0.339083:0.519427:0.015644:0.013143:0.016722:0.011392
Da-EPOCH:@0.339083:0.550767:0.440144:0.550767:0.440144:0.535011:0.339083:0.535011:0.014316:0.013143:0.006388:0.010314:0.011392:0.016722:0.015644:0.013143
radiotherapy:@0.339083:0.581935:0.460791:0.581935:0.460791:0.566179:0.339083:0.566179:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
BEACOPP + :@0.339083:0.597519:0.452152:0.597519:0.452152:0.581763:0.339083:0.581763:0.011045:0.010314:0.014239:0.015644:0.016722:0.011392:0.011392:0.005330:0.011661:0.005330
radiotherapy:@0.339083:0.613103:0.460791:0.613103:0.460791:0.597347:0.339083:0.597347:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314
2nd line::@0.339083:0.644271:0.417265:0.644271:0.417265:0.628515:0.339083:0.628515:0.010660:0.011738:0.013181:0.005330:0.003848:0.003848:0.011738:0.012508:0.005330
DHAP:@0.339083:0.659855:0.392173:0.659855:0.392173:0.644099:0.339083:0.644099:0.014316:0.013143:0.014239:0.011392
ICE:@0.339083:0.675439:0.369390:0.675439:0.369390:0.659683:0.339083:0.659683:0.004349:0.015644:0.010314
GDP:@0.339083:0.691023:0.381570:0.691023:0.381570:0.675267:0.339083:0.675267:0.016779:0.014316:0.011392
IGEV:@0.339083:0.706607:0.384034:0.706607:0.384034:0.690851:0.339083:0.690851:0.004349:0.016779:0.010314:0.013508
Nivolumab* and :@0.518942:0.519639:0.677057:0.519639:0.677057:0.503883:0.518942:0.503883:0.014239:0.003848:0.010660:0.012604:0.003848:0.011699:0.018049:0.013143:0.013123:0.008178:0.005330:0.013143:0.011738:0.013181:0.005330
pembroluzimab* – :@0.518942:0.535223:0.694414:0.535223:0.694414:0.519467:0.518942:0.519467:0.013123:0.012508:0.018049:0.013123:0.005715:0.012604:0.003848:0.011699:0.008178:0.003848:0.018049:0.013143:0.013123:0.008178:0.005330:0.009621:0.005330
checkpoint inhibitors:@0.518942:0.550807:0.711443:0.550807:0.711443:0.535051:0.518942:0.535051:0.012450:0.011738:0.012508:0.012450:0.009660:0.013123:0.012604:0.003848:0.011738:0.006523:0.005330:0.003848:0.011738:0.011738:0.003848:0.013123:0.003848:0.006523:0.012604:0.005792:0.007466
In patients not :@0.518942:0.581975:0.656756:0.581975:0.656756:0.566219:0.518942:0.566219:0.004349:0.011738:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.011738:0.012604:0.006523:0.005330
achieving remission, :@0.518942:0.597559:0.711056:0.597559:0.711056:0.581803:0.518942:0.581803:0.013143:0.012450:0.011738:0.003848:0.012508:0.010660:0.003848:0.011738:0.012950:0.005330:0.005713:0.012508:0.018049:0.003848:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330
autologous stem :@0.518942:0.613143:0.679289:0.613143:0.679289:0.597387:0.518942:0.597387:0.013143:0.011699:0.006523:0.012604:0.003848:0.012604:0.012950:0.012604:0.011699:0.007466:0.005330:0.007466:0.006523:0.012508:0.018049:0.005330
cells can be used to :@0.518942:0.628727:0.712655:0.628727:0.712655:0.612971:0.518942:0.612971:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.012450:0.013143:0.011738:0.005330:0.013123:0.012508:0.005330:0.011699:0.007466:0.012508:0.013181:0.005330:0.006523:0.012604:0.005330
intensify treatment:@0.518942:0.644311:0.691523:0.644311:0.691523:0.628555:0.518942:0.628555:0.003848:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.006042:0.010314:0.005330:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523
Allogeneic stem-:@0.518942:0.675479:0.675748:0.675479:0.675748:0.659723:0.518942:0.659723:0.014239:0.003848:0.003848:0.012604:0.012950:0.012508:0.011738:0.012508:0.003848:0.012450:0.005330:0.007466:0.006523:0.012508:0.018049:0.006388
cell transplant can :@0.518942:0.691063:0.697954:0.691063:0.697954:0.675307:0.518942:0.675307:0.012450:0.012508:0.003848:0.003848:0.005330:0.006523:0.005792:0.013143:0.011738:0.007466:0.013123:0.003848:0.013143:0.011738:0.006523:0.005330:0.012450:0.013143:0.011738:0.005330
cure patients with :@0.518942:0.706646:0.690273:0.706646:0.690273:0.690891:0.518942:0.690891:0.012450:0.011699:0.005711:0.012508:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.015990:0.003848:0.006523:0.011738:0.005330
resistant disease:@0.518942:0.722230:0.669319:0.722230:0.669319:0.706475:0.518942:0.706475:0.005713:0.012508:0.007466:0.003848:0.007466:0.006523:0.013143:0.011738:0.006523:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508
Intent of :@0.732513:0.519679:0.815198:0.519679:0.815198:0.503923:0.732513:0.503923:0.004349:0.011738:0.006523:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330
treatment :@0.732513:0.535263:0.831067:0.535263:0.831067:0.519507:0.732513:0.519507:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330
is curative. :@0.732513:0.550847:0.836442:0.550847:0.836442:0.535091:0.732513:0.535091:0.003848:0.007466:0.005330:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.005330
Predictors of  :@0.732513:0.566431:0.858609:0.566431:0.858609:0.550675:0.732513:0.550675:0.011392:0.005709:0.012508:0.013181:0.003848:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330:0.012604:0.006042:0.005317:0.005330
prognosis  :@0.732513:0.582015:0.830688:0.582015:0.830688:0.566259:0.732513:0.566259:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330:0.005330
include age,:@0.732513:0.597598:0.851047:0.597598:0.851047:0.581843:0.732513:0.581843:0.003848:0.011738:0.012450:0.003848:0.011699:0.013181:0.012508:0.005330:0.013143:0.012950:0.012508:0.005330
disease extent,:@0.732513:0.613182:0.872329:0.613182:0.872329:0.597426:0.732513:0.597426:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330:0.012508:0.009236:0.006523:0.012508:0.011738:0.006523:0.005330
site of disease,:@0.732513:0.628766:0.867614:0.628766:0.867614:0.613010:0.732513:0.613010:0.007466:0.003848:0.006523:0.012508:0.005330:0.012604:0.006042:0.005330:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.005330
raised LDH,:@0.732513:0.644350:0.835460:0.644350:0.835460:0.628594:0.732513:0.628594:0.005792:0.013143:0.003848:0.007466:0.012508:0.013181:0.005330:0.008890:0.014316:0.013143:0.005330
anaemia:@0.732513:0.659934:0.818084:0.659934:0.818084:0.644178:0.732513:0.644178:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143
Typical population :@0.732513:0.675518:0.910442:0.675518:0.910442:0.659762:0.732513:0.659762:0.008288:0.010314:0.013123:0.003848:0.012450:0.013143:0.003848:0.005330:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
survival rates for :@0.732513:0.691102:0.885491:0.691102:0.885491:0.675346:0.732513:0.675346:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.005792:0.013143:0.006523:0.012508:0.007466:0.005330:0.006042:0.012604:0.005792:0.005330
NHL patients are :@0.732513:0.706686:0.891005:0.706686:0.891005:0.690930:0.732513:0.690930:0.014239:0.013143:0.008890:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.013143:0.005707:0.012508:0.005330
around 50% and :@0.732513:0.722270:0.890878:0.722270:0.890878:0.706514:0.732513:0.706514:0.013143:0.005715:0.012604:0.011699:0.011738:0.013181:0.005330:0.010660:0.010660:0.014913:0.005330:0.013143:0.011738:0.013181:0.005330
for HL >80%:@0.732513:0.737854:0.837539:0.737854:0.837539:0.722098:0.732513:0.722098:0.006042:0.012604:0.005792:0.005330:0.013143:0.008890:0.005330:0.011661:0.010660:0.010660:0.014913
Very-high-:@0.094416:0.760278:0.194092:0.760278:0.194092:0.744059:0.094416:0.744059:0.013470:0.012315:0.006158:0.011161:0.008082:0.011545:0.004618:0.012700:0.011545:0.008082
grade or :@0.094416:0.776444:0.180237:0.776444:0.180237:0.760225:0.094416:0.760225:0.012700:0.006158:0.012700:0.012700:0.012315:0.005388:0.012315:0.006158:0.005388
very ag-:@0.094416:0.792610:0.173695:0.792610:0.173695:0.776391:0.094416:0.776391:0.010776:0.012315:0.006158:0.011161:0.005388:0.012700:0.012700:0.008082
gressive :@0.094416:0.808776:0.175619:0.808776:0.175619:0.792557:0.094416:0.792557:0.012700:0.006158:0.012315:0.008467:0.008467:0.004618:0.010776:0.012315:0.005388
lymphoma:@0.094416:0.824942:0.195631:0.824942:0.195631:0.808723:0.094416:0.808723:0.004618:0.011161:0.018088:0.012700:0.011545:0.012315:0.018088:0.012700
Treat  :@0.221147:0.760264:0.277313:0.760264:0.277313:0.744508:0.221147:0.744508:0.007620:0.005713:0.012508:0.013143:0.006523:0.005330:0.005330
aggres-:@0.221147:0.776430:0.292261:0.776430:0.292261:0.760674:0.221147:0.760674:0.013143:0.012950:0.012950:0.005709:0.012508:0.007466:0.006388
sively and :@0.221147:0.792596:0.318513:0.792596:0.318513:0.776840:0.221147:0.776840:0.007466:0.003848:0.010660:0.012508:0.003848:0.010314:0.005330:0.013143:0.011738:0.013181:0.005330
without :@0.221147:0.808762:0.295403:0.808762:0.295403:0.793006:0.221147:0.793006:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330
delay, :@0.221147:0.824928:0.284800:0.824928:0.284800:0.809173:0.221147:0.809173:0.013181:0.012508:0.003848:0.013143:0.010314:0.005330:0.005330
high likeli-:@0.221147:0.841094:0.310701:0.841094:0.310701:0.825339:0.221147:0.825339:0.011738:0.003848:0.012950:0.011738:0.005330:0.003848:0.003848:0.009660:0.012508:0.003848:0.003848:0.006388
hood of :@0.221147:0.857261:0.300579:0.857261:0.300579:0.841505:0.221147:0.841505:0.011738:0.012604:0.012604:0.013181:0.005330:0.012604:0.006042:0.005330
tumour :@0.221147:0.873427:0.292844:0.873427:0.292844:0.857671:0.221147:0.857671:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
lysis syn-:@0.221147:0.889593:0.295345:0.889593:0.295345:0.873837:0.221147:0.873837:0.003848:0.010314:0.007466:0.003848:0.007466:0.005330:0.007466:0.010314:0.011757:0.006388
drome:@0.221147:0.905759:0.283201:0.905759:0.283201:0.890003:0.221147:0.890003:0.013181:0.005713:0.012604:0.018049:0.012508
Intense inpatient :@0.339064:0.760238:0.499546:0.760238:0.499546:0.744482:0.339064:0.744482:0.004349:0.011738:0.006523:0.012508:0.011738:0.007466:0.012508:0.005330:0.003848:0.011738:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330
chemotherapy :@0.339064:0.775822:0.484883:0.775822:0.484883:0.760066:0.339064:0.760066:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330
regimens such :@0.339064:0.791406:0.477858:0.791406:0.477858:0.775650:0.339064:0.775650:0.005713:0.012508:0.012950:0.003848:0.018049:0.012508:0.011738:0.007466:0.005330:0.007466:0.011699:0.012450:0.011738:0.005330
as::@0.339064:0.806990:0.365003:0.806990:0.365003:0.791234:0.339064:0.791234:0.013143:0.007466:0.005330
hyperCVAD:@0.339064:0.822574:0.447897:0.822574:0.447897:0.806818:0.339064:0.806818:0.011738:0.010314:0.013123:0.012508:0.005792:0.015644:0.011159:0.014239:0.014316
CODOX-M-IVAC:@0.339064:0.838158:0.490050:0.838158:0.490050:0.822402:0.339064:0.822402:0.015644:0.016722:0.014316:0.016722:0.011719:0.006388:0.017684:0.006388:0.004349:0.011170:0.014239:0.015644
Da-EPOCH :@0.339064:0.853742:0.445455:0.853742:0.445455:0.837986:0.339064:0.837986:0.014316:0.013143:0.006388:0.010314:0.011392:0.016722:0.015644:0.013143:0.005330
+/- dose-dense :@0.339064:0.869326:0.485730:0.869326:0.485730:0.853570:0.339064:0.853570:0.011661:0.008409:0.006388:0.005330:0.013181:0.012604:0.007466:0.012508:0.006388:0.013181:0.012508:0.011738:0.007466:0.012508:0.005330
rituximab :@0.339064:0.884909:0.429657:0.884909:0.429657:0.869154:0.339064:0.869154:0.005792:0.003848:0.006523:0.011699:0.009236:0.003848:0.018049:0.013143:0.013123:0.005330
High-risk disease :@0.518923:0.760264:0.665298:0.760264:0.665298:0.744508:0.518923:0.744508:0.012565:0.003271:0.012373:0.011161:0.005811:0.005215:0.003271:0.006889:0.009082:0.004753:0.012604:0.003271:0.006889:0.011930:0.012565:0.006889:0.012506:0.005330
qualifies for alloge- :@0.518923:0.775848:0.688679:0.775848:0.688679:0.760092:0.518923:0.760092:0.012546:0.011122:0.012565:0.003271:0.003271:0.004397:0.004397:0.011930:0.006889:0.004753:0.005465:0.012027:0.005215:0.004753:0.012565:0.003271:0.003271:0.012027:0.012373:0.011930:0.006388:0.005330
neic stem-cell :@0.518923:0.791432:0.646215:0.791432:0.646215:0.775676:0.518923:0.775676:0.011161:0.011930:0.003271:0.011873:0.004753:0.006889:0.005946:0.011930:0.017472:0.005811:0.011873:0.011930:0.003271:0.003852:0.005330
transplant. An exciting  be achieved in :@0.518923:0.807016:0.879737:0.807043:0.879737:0.791287:0.518923:0.791260:0.005946:0.005215:0.012565:0.011161:0.006889:0.012546:0.003271:0.012565:0.011161:0.005946:0.004753:0.004753:0.013662:0.011161:0.004753:0.011930:0.008659:0.011873:0.003271:0.005946:0.003271:0.011161:0.012946:0.005330:0.012839:0.013123:0.012508:0.005330:0.013143:0.012450:0.011738:0.003848:0.012508:0.010660:0.012508:0.013181:0.005330:0.003848:0.011738:-0.570824
new therapy for :@0.518923:0.822600:0.664642:0.822600:0.664642:0.806844:0.518923:0.806844:0.011161:0.011930:0.015413:0.004753:0.005946:0.011161:0.011930:0.005215:0.012565:0.012546:0.009737:0.004753:0.005465:0.012027:0.005788:0.005330
resistant disease is :@0.518923:0.838184:0.680309:0.838184:0.680309:0.822428:0.518923:0.822428:0.005136:0.011930:0.006889:0.003271:0.006889:0.005946:0.012565:0.011161:0.005946:0.004753:0.012604:0.003271:0.006889:0.011930:0.012565:0.006889:0.011930:0.004753:0.003271:0.007468:0.005330
Chimeric Antigen :@0.518923:0.853768:0.678342:0.853768:0.678342:0.838012:0.518923:0.838012:0.015067:0.011161:0.003271:0.017472:0.011930:0.005215:0.003271:0.011873:0.004753:0.013662:0.011161:0.005946:0.003271:0.012373:0.011930:0.011734:0.005330
Receptor T (CAR-T)* :@0.518923:0.869352:0.698431:0.869352:0.698431:0.853596:0.518923:0.853596:0.011103:0.011930:0.011873:0.011930:0.012546:0.005946:0.012027:0.005215:0.004753:0.007620:0.004753:0.006523:0.015067:0.013662:0.011103:0.005811:0.007620:0.006523:0.008174:0.005330
cells utilising adoptive :@0.518923:0.884936:0.713115:0.884936:0.713115:0.869180:0.518923:0.869180:0.011873:0.011930:0.003271:0.003271:0.006889:0.004753:0.011122:0.005946:0.003271:0.003271:0.003271:0.006889:0.003271:0.011161:0.012373:0.004753:0.012565:0.012604:0.012027:0.012546:0.005946:0.003271:0.010083:0.012506:0.005330
immunotherapy :@0.518923:0.900520:0.666456:0.900520:0.666456:0.884764:0.518923:0.884764:0.003271:0.017472:0.017472:0.011122:0.011161:0.012027:0.005946:0.011161:0.011930:0.005215:0.012565:0.012546:0.010316:0.005330
directed at tumour :@0.518923:0.916104:0.691036:0.916104:0.691036:0.900348:0.518923:0.900348:0.012604:0.003271:0.005134:0.011930:0.011873:0.005946:0.011930:0.012604:0.004753:0.012565:0.005946:0.004753:0.005946:0.011122:0.017472:0.012027:0.011122:0.005786:0.005330
cells:@0.518923:0.931688:0.556734:0.931688:0.556734:0.915932:0.518923:0.915932:0.011873:0.011930:0.003271:0.003271:0.007466
Intent of :@0.732494:0.760291:0.815179:0.760291:0.815179:0.744535:0.732494:0.744535:0.004349:0.011738:0.006523:0.012508:0.011738:0.006523:0.005330:0.012604:0.006042:0.005330
treatment is :@0.732494:0.775875:0.847693:0.775875:0.847693:0.760119:0.732494:0.760119:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.003848:0.007466:0.005330
curative and can :@0.732494:0.791459:0.900500:0.791459:0.900500:0.775703:0.732494:0.775703:0.012450:0.011699:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.012450:0.013143:0.011738:0.005330
40-80% of cases, :@0.732494:0.822627:0.889435:0.822627:0.889435:0.806871:0.732494:0.806871:0.010660:0.010660:0.006388:0.010660:0.010660:0.014913:0.005330:0.012604:0.006042:0.005330:0.012450:0.013143:0.007466:0.012508:0.007466:0.005330:0.005330
depending on :@0.732494:0.838211:0.872271:0.838211:0.872271:0.822455:0.732494:0.822455:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.005330:0.012604:0.011738:0.005330
patient age :@0.732494:0.853794:0.849161:0.853794:0.849161:0.838039:0.732494:0.838039:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.005330:0.013143:0.012950:0.012508:0.005330
and the growth :@0.732494:0.869378:0.882818:0.869378:0.882818:0.853623:0.732494:0.853623:0.013143:0.011738:0.013181:0.005330:0.006523:0.011738:0.012508:0.005330:0.012950:0.005698:0.012604:0.015990:0.006523:0.011738:0.005330
and genetic :@0.732494:0.884962:0.853741:0.884962:0.853741:0.869206:0.732494:0.869206:0.013143:0.011738:0.013181:0.005330:0.012950:0.012508:0.011738:0.012508:0.006523:0.003848:0.012450:0.005330
characteristics of :@0.732494:0.900546:0.896940:0.900546:0.896940:0.884790:0.732494:0.884790:0.012450:0.011738:0.013143:0.005792:0.013143:0.012450:0.006523:0.012508:0.005792:0.003848:0.007466:0.006523:0.003848:0.012450:0.007466:0.005330:0.012604:0.006042:0.005330
the tumour:@0.732494:0.916130:0.834960:0.916130:0.834960:0.900374:0.732494:0.900374:0.006523:0.011738:0.012508:0.005330:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792